Cytokines in rheumatoid arthritis - shaping the immunological landscape (Q38666239)

5 September 2017

title

Cytokines in rheumatoid arthritis - shaping the immunological landscape (English)

1 reference

5 September 2017

1 reference

1 reference

John D Isaacs

3

0 references

Christopher D Buckley

series ordinal

2

object named as

Christopher D Buckley

1 reference

5 September 2017

Iain B McInnes

1

1 reference

5 September 2017

language of work or name

English

0 references

publication date

10 December 2015

1 reference

Nature Reviews Rheumatology

5 September 2017

published in

1 reference

5 September 2017

volume

12

1 reference

5 September 2017

issue

1

1 reference

5 September 2017

page(s)

63-68

1 reference

The disease formerly known as rheumatoid arthritis

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

The pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Cytokines in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Innate Lymphoid Cells: Emerging Insights in Development, Lineage Relationships, and Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

IL-6 in inflammation, immunity, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

The interleukin-1 family: back to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

The interferon signature in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

GM-CSF as a therapeutic target in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Th17 cytokines and arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

The IL-23-IL-17 axis in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

A four-step model for the IL-6 amplifier, a regulator of chronic inflammations in tissue-specific MHC class II-associated autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

IL-7- and IL-15-mediated TCR sensitization enables T cell responses to self-antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

IL-21 as a therapeutic target in inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

IL-7 and IL-15: biology and roles in T-Cell immunity in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

IL-12 family cytokines: immunological playmakers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Interleukin-35 induces regulatory B cells that suppress autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Why does chronic inflammation persist: An unexpected role for fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Epigenetic contributions in the development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Synovial fibroblasts spread rheumatoid arthritis to unaffected joints

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Metabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

The impact of inflammation on metabolomic profiles in patients with arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

The fibroblast as a therapeutic target in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Cadherin 11 promotes invasive behavior of fibroblast-like synoviocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Interactome networks and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Bone: The concept of RANKL-independent osteoclastogenesis refuted

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Interleukin-1 function and role in rheumatic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Comorbidities: Stroke risk increased after herpes zoster infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Systemic lupus erythematosus: Leptin linked to SLE

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Autoimmunity: Apoptotic cells induce immune memory.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a phase II, randomized, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

IL-6 and matrix metalloproteinase-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.171

Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases

31 March 2020

1 reference

12 December 2020

TNF biology, pathogenic mechanisms and emerging therapeutic strategies

1 reference

12 December 2020

Successes and failures of chemokine-pathway targeting in rheumatoid arthritis

1 reference

12 December 2020

Targeting GM-CSF in inflammatory diseases

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2015.171

1 reference

Dimensions Publication ID

5 September 2017

1030876740

0 references

Fatcat ID

release_uryo7jnqyvcg7ksgdadampxfum

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uryo7jnqyvcg7ksgdadampxfum

24 November 2022

mapped directly with Wikidata item

1 reference